Related Experiment Video
Updated: Jan 18, 2026
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
Dose optimization of NMDA for rat model of infantile spasms: Approach using EEG, behavior (Seizure) and
Muskan Uniyal1, Arushi Sandhu1, Aniket Gupta1
1Department of Pharmacology, Research Block B, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Insights
Researchers optimized N-methyl-D-aspartate (NMDA) dosage to create a safer animal model for Infantile Epileptic Spasms Syndrome (IESS). This refined model effectively mimics IESS pathology with reduced toxicity, aiding future research.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Infantile Epileptic Spasms Syndrome (IESS), or West syndrome, is a severe early-childhood epilepsy.
- Key features include epileptic spasms, developmental issues, and hypsarrhythmia on EEG.
- Existing animal models, particularly NMDA-induced ones, suffer from high toxicity.
Purpose of the Study:
- To optimize the NMDA dose for inducing IESS-like features in rats.
- To reduce model toxicity and mortality while preserving pathological characteristics.
- To validate a safer and more effective preclinical model for IESS research.
Main Methods:
- Administered an optimized, reduced dose of NMDA to rats.
- Assessed model validity using EEG recordings, behavioral tests, and brain histopathology.
- Analyzed EEG for abnormalities, examined brain tissue for neuronal damage, and evaluated behavior.
Main Results:
- EEG analysis revealed significant abnormalities, including irregular wave patterns and increased interictal activity in NMDA-treated rats.
- Histological examination confirmed neuronal damage, such as nuclear pyknosis.
- Behavioral tests showed no significant differences in locomotion, memory, or anxiety between groups.
Conclusions:
- An optimized, reduced NMDA dose reliably induces IESS-like features in rats.
- This method offers a safer and effective alternative to existing NMDA-induced models.
- The refined model is suitable for future preclinical investigations into IESS mechanisms and treatments.
Abstract:
Infantile Epileptic Spasms Syndrome (IESS), also referred to as West syndrome, is a severe epileptic disorder that emerges during early childhood. It is marked by characteristic epileptic spasms, developmental stagnation or regression, and a distinctive electroencephalogram (EEG) pattern known as hypsarrhythmia. To better understand the underlying mechanisms of IESS, various genetic and chemically induced animal models have been developed. Among these, the N-methyl-D-aspartate (NMDA) induced model is widely used, although it is often associated with high toxicity and mortality. In the study, we optimized the NMDA dose to reduce toxicity while maintaining the pathological features of IS. The validity of the model was assessed through EEG recordings, behavioural assessments, and brain histopathology. EEG analysis in the NMDA treated group revealed prominent abnormalities, including irregular wave patterns and elevated interictal activity. Histological examination showed signs of neuronal damage, such as nuclear pyknosis, in the model group. Behavioural tests assessing locomotion, memory, stereotypic activity, and anxiety like behaviour did not show significant differences between control and NMDA exposed rats. These findings demonstrate that a reduced and optimised dose of NMDA can reliably induce IS-like features in rats, offering a safer and effective model for future preclinical research.
More Related Videos
08:47Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017